Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference
Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the 2026 Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026.
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the 2026 Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026. A corporate presentation is scheduled for 2:15 p.m. Eastern Time and will be accessible live via Vanda's website under the Investors tab.
Investors are advised to register at the conference site at least 15 minutes early to download required software; an archived link will be available on Vanda's site for approximately 30 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – VNDA
On Feb 27, the first trading day after this news, VNDA closed 3.60% above the previous close.
Data tracked by StockTitan Argus for the Feb 27 session.
Key Figures
- Conference date
- March 11, 2026
- Citizens Life Sciences Conference participation
- Presentation time
- 2:15 p.m. ET
- Scheduled corporate presentation slot
- Archive duration
- 30 days
- Length of archived conference webcast availability
- Early login
- 15 minutes
- Suggested early arrival to register and install software
Historical Context
-
FDA accepted imsidolimab BLA for treating generalized pustular psoriasis.
-
FDA approved BYSANTI for bipolar I disorder and schizophrenia in adults.
-
2025 results showed revenue growth but a large net loss and tax allowance.
-
Company scheduled Q4 and full-year 2025 results release and call details.
-
FDA said HETLIOZ sNDA for jet lag disorder cannot be approved as submitted.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The corporate presentation given at the Citizens Life Sciences Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-2026-citizens-life-sciences-conference-302699013.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.